HIV/AIDS Research

A recognized global leader in the KSHV community

Scientists developed a bioinformatics pipeline to more accurately detect HIV drug resistance and potentially improve the quality of antiretroviral therapies for people living with HIV.

Scientists and clinicians whose discoveries have shaped the understanding of HIV disease will provide updates on the status of HIV/AIDS research and patient care.

Study demonstrates variation in HLA proteins in people living with HIV affects the severity of their condition. 

Research shows the potential for a new drug that might only need to be taken twice a year to prevent HIV infection. The drug manufacturer is planning a clinical trial. 

Study subject showed complications in antiretroviral therapy efficacy from inflammation and secondary infections.

People with HIV on long-term antiretroviral therapy show signs of brain damage and cognitive impairment on a battery of imaging, laboratory, and functional tests, and they report a greater degree of difficulty with the routine tasks of everyday life, according to a new study. The study, published in April in the journal Neurology, is the first…

Each year, the Frederick National Laboratory offers its scientists an opportunity to compete for funding to conduct the research they view as critical to advance biomedical research but is outside the scope of their daily research activities. This year, three proposals earned funding through the program, known as the Laboratory Directed…

Five new projects led by Frederick National Laboratory for Cancer Research (FNL) scientists have earned Laboratory Directed Exploratory Research (LDER) funding for the upcoming fiscal year. The LDER program, which was modeled after the U.S. Department of Energy’s Laboratory Directed Research and Development program, provides FNL scientists…

Natural immune response may point to possible cure for others.